Latest price-to-book ratio
enGene Therapeutics Price-to-book ratio
Direct answer
enGene Therapeutics's price-to-book ratio is 0.45x.
The verified market snapshot reports 0.45x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free enGene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 0.45x
Explore related company data
View enGene Therapeutics's market capitalizationView enGene Therapeutics's return on equityView enGene Therapeutics's dividend yieldView enGene Therapeutics's 52-week price rangeView enGene Therapeutics's profit marginView enGene Therapeutics's debt-to-equity ratioView all enGene Therapeutics key metricsReturn to enGene Therapeutics profile